News - OICR

  • oicr.on.ca
  • Front page
  • News Feed

August 22, 2018

Meet the researchers: Ratheesh Subramaniam

Ratheesh Subramaniam talks about his work in OICR’s Drug Discovery team and how it could help doctors make a difference in treating cancer patients.

Share on Facebook Share on Twitter Share on Linkedin

Tags: Drug Discovery, Meet the researchers, Ratheesh Subramaniam, Therapeutic Innovation, Video

Subscribe to our newsletter

Our newsletter is the best way to stay up to date with what's happening at the Institute.

Sign up now

News releases

  • Philanthropic donation moves The Alex U. Soyka Pancreatic Cancer Research Project: An International Partnership into Phase II
    June 24, 2020

  • FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund
    June 23, 2020

  • Unprecedented exploration generates most comprehensive map of cancer genomes charted to date
    February 5, 2020

  • New tumour-driving mutations discovered in the under-explored regions of the cancer genome
    January 20, 2020

  • Unique Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer
    January 13, 2020

  • See all news releases

Media Contact

Hal Costie
Senior Communications Officer

hal.costie@oicr.on.ca
Telephone: 647-963-5289

Tweets by @OICR_news

For more information on OICR's research, careers, events and education, visit our corporate website: OICR.ON.CA

© 2020 Ontario Institute for Cancer Research. All rights reserved.
Terms and Conditions | Privacy statement | Policies

Ontario

Funding provided by the Government of Ontario.

This website uses cookies in order to optimize the user’s experience. To learn more about how we use cookies on this website, please review our Website Privacy Statement (https://oicr.on.ca/website-privacy-statement). Your browser settings may allow you to turn off cookies. By continuing to use our website site without changing your browser settings, you consent to our use of cookies in accordance with Website Privacy Statement.